Navigation Links
Pixel Bridge Works With Anika Therapeutics to Launch New Website
Date:8/20/2008

Pixel Bridge, a Boston-based interactive marketing and Web development firm recently announced the launch of a new website for Anika Therapeutics - www.anikatherapeutics.com. Anika Therapeutics (NASDAQ: ANIK) develops products that address the fast-growing joint health, aesthetic, ophthalmic, veterinary and anti-adhesion markets. The company worked with Pixel Bridge to plan, design, develop and implement the new site.

Boston, MA (PRWEB) August 20, 2008 -- Pixel Bridge, a Boston-based interactive marketing and Web development firm recently announced the launch of a new website for Anika Therapeutics - www.anikatherapeutics.com. Anika Therapeutics (NASDAQ: ANIK) develops products that address the fast-growing joint health, aesthetic, ophthalmic, veterinary and anti-adhesion markets. The company worked with Pixel Bridge to plan, design, develop and implement the new site.

For more than 20 years, Anika has been a leader in developing therapies that leverage the benefits of hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body that enhances joint function and coats, protects, cushions and lubricates soft tissues. The company is recognized worldwide as a provider of premium HA products that are effective, safe and long-lasting.

The company's new interactive property is version 2.0 of the site. The key underlying goals associated with the project were to:

  • Effectively educate site visitors about the company's products


    '/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Siemens and Xintek Form Joint Venture to Develop Nanotechnology-Enabled Multi-Pixel X-ray Tubes
2. WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing
3. New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden)
4. Rib-X Pharmaceuticals to Present at Cambridge Healthtech Institutes 2nd Annual Challenge of Antibacterial Development Conference
5. Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge
6. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
7. NIST team proves bridge from conventional to molecular electronics possible
8. Antibody Engineering Company f-Star Opens Second Research Site in Cambridge, UK
9. Woodbridge Offers the Broadest Range of BioFoam(TM) Green Polyurethane Automotive Interior Applications
10. Cambridge Major Appoints Professor John Hartwig as Scientific Advisor
11. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...National Institute of Standards and Technology (NI...ive method for detecting and measuring elusive haz...sible spoilage in food or pesticides distributed i...ore sensitive than conventional techniques for det...ike water molecules, having distinct electrically ...
(Date:11/18/2009)...D, Calif., Nov. 18 Sanga...day that data from the University of Pennsylvania ...gamo,s zinc finger nuclease (ZFN) based product, S...turely disclosed on the internet. ,, Data were ... Pennsylvania School of Medicine from a single sub...
(Date:11/18/2009)... YORK, Nov. 18 Reportlinker.com an...able in its catalogue. ,, Biotechnology Reage.../www.reportlinker.com/p0164375/Biotechnology-Reage...prnewswire&utm_medium=pr&utm_campaign=prne...complex chemical compounds used in a range of biot...
(Date:11/18/2009)...significantly reduces key cardiac enzymes at multi...ted at American Heart Association 2009 Scientific ... Viron Therapeutics Inc., a biotechnology company ...otein therapeutics derived from pathogens, today r...aluating VT-111 (Serp-1), an anti-inflammatory pro...
Breaking Biology Technology:Prototype NIST method detects and measures elusive hazards 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4
...ce Plants to Further Develop Plant Traits for Biof...ormance Plants Inc. (PPI), a global leader in agri... Sustainable Development Technology Canada (SDTC) ...will be receiving up to $5,565,063 in funding from... technologies that improve conversion of cellulose...
... significant contract with Major Biopharmaceutical...poration (Pink Sheets: MNCN), is pleased to announ...rs LLC, is changing its name to MPS BioPharm to be...eived a contract and deposits from a major global ... , The contract is for a Clean-In-Place (CIP) syst...
... -- As synthetic biologists cram more and more gen...ganisms produce ever more complex drugs and chemic...ne a step further. , They have assembled differen...etic microtissues that can perform functions such ... more complex biological capabilities than a singl...
Other Biology Technology:Canadian Government Announces Funding for Leading Biotechnology Firm's Project 2Canadian Government Announces Funding for Leading Biotechnology Firm's Project 3Mach One Subsidiary Modular Process Constructors LLC Changes Name to MPS BioPharm to Better Reflect its Vision 2Assembling cells into artificial 3-D microtissues, including a tiny gland 2Assembling cells into artificial 3-D microtissues, including a tiny gland 3
(Date:11/20/2009)...are invited to contribute their abstracts to the W...10), the largest global meeting devoted to all asp...nd patient care. The Congress will be held in Flor...y, abstracts can be submitted online at http://ww... is February 4, 2010. , IOF and ESCEO are please...
(Date:11/20/2009)...n, Mass., November 19, 2009 The estimated 4.6 mil... be at risk of developing respiratory symptoms due...a questionnaire study undertaken earlier this year...chool of Veterinary Medicine. , The studywhich p...ound that 50 percent of individuals working in bar...
(Date:11/20/2009)...ember 19th 2009 - Bacteria possess an ingenious me...lding blocks of the cell. This is the new finding ...s of VIB, a life sciences research institute in Fl...it Brussel. The scientists made this discovery by ...herichia coli . By means of this model organism, t...
Breaking Biology News(10 mins):Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3Barn personnel experience higher-than-average rates of respiratory symptoms 2Biologists discover bacterial defense mechanism against aggressive oxygen 2Wrist fracture patients less likely to be evaluated for osteoporosis 58645 1Wrist fracture patients less likely to be evaluated for osteoporosis 58645 2Paradoxically food insecurity may be underlying contributor to overweight 58642 1Paradoxically food insecurity may be underlying contributor to overweight 58642 2Science survey ranks top biopharma employers 10209 1
...M, Ala. Scientists at the University of Alabama a... X-ray crystallography to uncover new details abou... the understanding of how one protein in viral inf...ving high-resolution detail of this protein on han...inflammation and immune diseases such as atheroscl...
... Key, Fla.-- The University of Miamis Rosenstiel S...today that it has selected Dennis J. McGillicuddy,...ward. McGillicuddy, a senior scientist in the depa... the Woods Hole Oceanographic Institution (WHOI) i...physical-biological interactions in the ocean. His...
...Emission Tomography (PET) was much more sensitive ...s in detecting response to treatment in sarcoma pa...e first to directly compare PET to CT scanning. , ...s. If conventional imaging fails to detect treatme... that in fact are working and study participants m...
Other Biology News:Poxvirus potency uncovered in new atomic map 2Oceanographer Dennis J. McGillicuddy, Jr. receives 34th annual Rosenstiel Award 2Positron emission tomography superior to standard evaluation tools in measuring treatment response 2Positron emission tomography superior to standard evaluation tools in measuring treatment response 3
AVR9-8 Stream-Select Valve from Bio-Rad
...eous: Versatile stain for staining RNA (bluish-pur...harides Assay: TLC ≥ 90 % Cation traces:... 5 mg/kg Cr ≤ 5 mg/kg Cu ≤ 5 mg/kg Fe .../kg Mn ≤ 5 mg/kg Na ≤ 50 mg/kg Ni X...
... Tpersonal thermocycler provides maximum performan... Peltier elements, high heating and cooling rates ...s. With a maximum capacity of 48 x 0.2ml tubes, th...e expensive 96 well instruments. Alternatively, th...
...Deparaffinization Solution is available in a ready...gent for dewaxing paraffin-embedded tissue section...u hybridization, or other analytical methods. The ...f dipping the slides in a series of baths of xylen...
Biology Products: